From: Psychometric properties of the Greek Diabetes Treatment Satisfaction Questionnaire
DTSQ | Predictors | Β | SE | t | P-sig | R2 |
---|---|---|---|---|---|---|
Satisfaction | (Constant) | 30.976 | 2.686 | 11.532 | < 0.001 | 0.285 |
Gender (Female) | 0.011 | 0.765 | 0.015 | 0.988 | ||
Age1 | -1.031 | 0.406 | -2.540 | 0.012 | ||
Years therapy1 | -0.399 | 0.514 | -0.777 | 0.438 | ||
BMI class1 | 0.019 | 0.416 | 0.045 | 0.964 | ||
HbA1c1 | -1.874 | 0.511 | -3.668 | < 0.001 | ||
Control method1 | -4.586 | 0.997 | -4.601 | < 0.001 | ||
Comorbidity | -1.002 | 0.897 | -1.117 | 0.266 | ||
Coronary/vascular disease | -0.340 | 0.840 | -0.405 | 0.686 | ||
Microvascular disease | 2.398 | 1.444 | 1.661 | 0.099 | ||
Diabetic foot | -3.190 | 1.558 | -2.047 | 0.042 | ||
Perceived Hyperglycaemia | (Constant) | 0.944 | 0.740 | 1.275 | 0.204 | 0.232 |
Gender (Female) | -0.254 | 0.211 | -1.205 | 0.230 | ||
Age1 | -0.121 | 0.112 | -1.082 | 0.281 | ||
Years therapy1 | 0.198 | 0.142 | 1.397 | 0.164 | ||
BMI class1 | -0.099 | 0.115 | -0.864 | 0.389 | ||
HbA1c1 | 0.676 | 0.141 | 4.800 | < 0.001 | ||
Control method1 | 0.709 | 0.275 | 2.583 | 0.011 | ||
Comorbidity | -0.047 | 0.247 | -0.189 | 0.851 | ||
Coronary/vascular disease | 0.384 | 0.231 | 1.660 | 0.099 | ||
Microvascular disease | -0.303 | 0.398 | -0.762 | 0.447 | ||
Diabetic foot | 0.233 | 0.429 | 0.544 | 0.587 | ||
Perceived Hypoglycaemia | (Constant) | 1.815 | 0.674 | 2.694 | 0.008 | 0.268 |
Gender (Female) | -0.281 | 0.192 | -1.463 | 0.145 | ||
Age1 | -0.077 | 0.102 | -0.757 | 0.450 | ||
Years therapy1 | 0.202 | 0.129 | 1.569 | 0.119 | ||
BMI class1 | -0.115 | 0.104 | -1.105 | 0.271 | ||
HbA1c1 | 0.698 | 0.128 | 5.444 | < 0.001 | ||
Control method1 | 0.768 | 0.250 | 3.073 | 0.002 | ||
Comorbidity | 0.043 | 0.225 | 0.190 | 0.850 | ||
Coronary/vascular disease | 0.148 | 0.211 | 0.704 | 0.482 | ||
Microvascular disease | -0.646 | 0.362 | -1.784 | 0.076 | ||
Diabetic foot | -0.265 | 0.391 | -0.677 | 0.499 |